Table 3 Neurodevelopmental abnormalities in survivors at 6 months of age (n=39)a

From: Ascorbic acid combined with ibuprofen in hypoxic ischemic encephalopathy: a randomized controlled trial

  Intervention group (n=19) Control group (n=20) P-value
Neurological exam
 Normal 10 (53) 9 (45) 0.88
 Abnormal 9 (47) 11 (55)  
DDST II
 Normal 9 (47) 8 (40)  
 Caution 4 (21) 4 (20) 0.85
 Delayed 6 (32) 8 (40)  
Seizures 1 (5) 2 (10) 0.85
Overall outcomes
 Normal 8 (42) 8 (40)  
 Spastic quadriplegia 4 (21) 5 (25)  
 Developmental delay 4 (21) 2 (10)  
 Global developmental delay 2 (11) 3 (15) 0.56
 Motor delay 1 (5) 2 (10)  
  1. aData are expressed as numbers (%), χ2 test was used.